Načítá se...

BET Inhibition Suppresses S100A8 and S100A9 Expression in Acute Myeloid Leukemia Cells and Synergises with Daunorubicin in Causing Cell Death

S100A8 and S100A9 are both members of the S100 family and have been shown to play roles in myeloid differentiation, autophagy, apoptosis, and chemotherapy resistance. In this study we demonstrate that the BET-bromodomain inhibitor JQ1 causes rapid suppression of S100A8 and S100A9 mRNA and protein in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bone Marrow Res
Hlavní autoři: Stewart, Helen J. S., Chaudry, Sabah, Crichlow, Asante, Luiling Feilding, Freya, Chevassut, Timothy J. T.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000862/
https://ncbi.nlm.nih.gov/pubmed/29955397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5742954
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!